What’s New in Quality and Regulatory Expectations for Laboratories? [2022]
Continual Improvement
This “Continual Improvement” webinar will provide an overview of new or changed regulations for 2022, and other regulatory issues that have the potential to affect clinical laboratories. The latter half of the year has been very busy for laboratory-related regulations and legislation, including the potential VALID Act and its impact to laboratory developed tests (LDTs), the SALSA Act which seeks to address reimbursement issues with the Protecting Access to Medicare Act (PAMA), and the potential end of the COVID-19 public health emergency.
Shannon Bennett, M.S.
Director, Regulatory Affairs
Department of Laboratory Medicine Quality Management Services
Mayo Clinic, Rochester, Minnesota
Jennifer Nosbisch, M.B.A.
CLIA Compliance Program Manager
Integrity and Compliance Office
Mayo Clinic, Rochester, Minnesota
Upon completion of this activity, participants should be able to:
This webinar is appropriate for laboratory administrators and managers, quality assurance and control staff, supervisors, and other laboratory personnel who are dedicated to continuous quality and process improvement.
The following types of credit are offered for this event:
Mayo Clinic Laboratories is approved as a provider of continuing education programs in the Clinical Laboratory Sciences by the ASCLS P.A.C.E.® program. This program has been approved for a maximum of 1.0 P.A.C.E.® contact hour.
Mayo Clinic Laboratories is approved as a Continuing Education Accrediting Agency for the Clinical Laboratory Sciences for the State of Florida. Florida Board of Clinical Laboratory Personnel has designated this program for Supervisor/Administration, Quality Control/Quality Assurance, and Safety credit. This program has been approved for 1.0 contact hour.
1. Watch the video.
2. Complete the posttest and evaluation that launches immediately following the video.
3. Generate and print your certificate(s).
Level of instruction for this program is basic.
Credit for this recording expires on: 12/14/2024
Course director(s), planning committee, faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Safeguards against commercial bias have been put in place. Faculty members also will disclose any off-label and/or investigational use of pharmaceuticals or instruments discussed in their presentations. Disclosure of this information will be published in course materials so those participants in the activity may formulate their own judgments regarding the presentations.
Contact us: mcleducation@mayo.edu